This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: 3B Pharmaceuticals Gmbh. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Jan Ungewiß: Innovator in Neurotensin Receptor Ligands
Introduction
Jan Ungewiß is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of neurotensin receptor ligands. With a total of 2 patents, his work is paving the way for advancements in therapeutic applications.
Latest Patents
Ungewiß's latest patents include innovative compounds related to neurotensin receptor ligands. The first patent describes a compound of formula (I) that includes various amino acids and alkyl groups, aimed at enhancing receptor binding. The second patent focuses on a conjugate comprising a structure that allows for targeted binding to specific receptors, utilizing a combination of targeting and adapter moieties.
Career Highlights
Jan Ungewiß is currently associated with 3b Pharmaceuticals GmbH, where he continues to push the boundaries of pharmaceutical research. His work is characterized by a strong emphasis on the development of compounds that can effectively interact with neurotensin receptors, which are crucial in various physiological processes.
Collaborations
Ungewiß collaborates with notable colleagues such as Frank Osterkamp and Christian Haase, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jan Ungewiß stands out as a key figure in the field of neurotensin receptor research. His innovative patents and collaborative efforts are instrumental in advancing therapeutic options in pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile